Celgene Corp. is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Recent Equity Price Chart

Loading...

Bullish Trades

Call trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Put Login To View Login To View Login To View Login To View Login To View Login To View Login To View $117,000 Login To View Login To View about 3 hours ago Login To View